| RS201706900 |
ELP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial dysautonomia, Familial dysautonomia |
| RS201707021 |
NEB
|
Health Risk |
Conflicting classifications of pathogenicity |
Nemaline myopathy 2, Inborn genetic diseases |
| RS201707267 |
ABCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
ABCA4-related disorder, Retinal dystrophy |
| RS201707833 |
GRIN2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Landau-Kleffner syndrome, Inborn genetic diseases |
| RS201707868 |
KCNJ1
|
Health Risk |
Pathogenic/Likely pathogenic |
Bartter disease type 2, Bartter disease type 2 |
| RS201707963 |
HAX1
|
Health Risk |
Pathogenic/Likely pathogenic |
HAX1-related disorder, Kostmann syndrome |
| RS201708587 |
KDR
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS201708813 |
BARD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS201708930 |
TNXB
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, Cardiovascular phenotype |
| RS201709328 |
KMT2D
|
Health Risk |
Conflicting classifications of pathogenicity |
Kabuki syndrome, KMT2D-related disorder |
| RS201709513 |
USH2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Usher syndrome type 2A, Retinitis pigmentosa 39 |
| RS201709518 |
DRP2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS201709592 |
CCDC40
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia, Primary ciliary dyskinesia 15 |
| RS201709900 |
POLR3A
|
Health Risk |
Conflicting classifications of pathogenicity |
Leukodystrophy, hypomyelinating |
| RS201710257 |
CPS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital hyperammonemia, type I |
| RS201710470 |
USH2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Usher syndrome type 2A, Retinitis pigmentosa 39 |
| RS201710642 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Tuberous sclerosis syndrome |
| RS201711087 |
PYGM
|
Health Risk |
Conflicting classifications of pathogenicity |
Glycogen storage disease, type V |
| RS201711319 |
SACS
|
Health Risk |
Conflicting classifications of pathogenicity |
Spastic paraplegia, Inborn genetic diseases |
| RS201711375 |
AIFM1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Combined oxidative phosphorylation deficiency |
| RS201711410 |
GDF2
|
Health Risk |
Conflicting classifications of pathogenicity |
Telangiectasia, hereditary hemorrhagic |
| RS201711669 |
PITRM1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS201711670 |
LIFR
|
Health Risk |
Conflicting classifications of pathogenicity |
LIFR-related disorder, LIFR-related disorder |
| RS201712580 |
SPEF2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS201712827 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Neurofibromatosis |
| RS201712933 |
SPTBN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS201712942 |
ZAP70
|
Health Risk |
Conflicting classifications of pathogenicity |
Combined immunodeficiency due to ZAP70 deficiency, Combined immunodeficiency due to ZAP70 deficiency |
| RS201713027 |
PCDH19
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 9 |
| RS201713384 |
CNOT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Holoprosencephaly 12 with or without pancreatic agenesis |
| RS201713621 |
DAG1
|
Health Risk |
Conflicting classifications of pathogenicity |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A9 |
| RS201713771 |
CNGA3
|
Health Risk |
Likely pathogenic |
Achromatopsia 2, Achromatopsia 2 |
| RS201714031 |
AMPD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Muscle AMP deaminase deficiency, Muscle AMP deaminase deficiency |
| RS201714147 |
BMP1
|
Health Risk |
Conflicting classifications of pathogenicity |
BMP1-related disorder, BMP1-related disorder |
| RS201714199 |
CFHR5
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS201714423 |
CLCN1
|
Health Risk |
Pathogenic |
Congenital myotonia, autosomal recessive form |
| RS201714436 |
DBT
|
Health Risk |
Conflicting classifications of pathogenicity |
Maple syrup urine disease, Maple syrup urine disease |
| RS201714602 |
SLC26A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Achondrogenesis, type IB |
| RS201714645 |
GCDH
|
Health Risk |
Likely pathogenic |
Glutaric aciduria, type 1 |
| RS201715157 |
PTPRC
|
Health Risk |
Conflicting classifications of pathogenicity |
Immunodeficiency 104, PTPRC-related disorder |
| RS201715228 |
SYNE2
|
Health Risk |
Conflicting classifications of pathogenicity |
Emery-Dreifuss muscular dystrophy 5, autosomal dominant |
| RS201715448 |
SEMA4A
|
Health Risk |
Conflicting classifications of pathogenicity |
Cone-rod dystrophy 10, Retinitis pigmentosa |
| RS201715521 |
LDB3
|
Health Risk |
Conflicting classifications of pathogenicity |
Myofibrillar myopathy 4, Cardiomyopathy |
| RS201715539 |
INF2
|
Health Risk |
Conflicting classifications of pathogenicity |
Focal segmental glomerulosclerosis 5, Charcot-Marie-Tooth disease dominant intermediate E |
| RS201715603 |
MFN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary motor and sensory neuropathy with optic atrophy, Charcot-Marie-Tooth disease type 2 |
| RS201715967 |
SYNE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Emery-Dreifuss muscular dystrophy 4, autosomal dominant |
| RS201716258 |
COL4A2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS201716417 |
CPS1
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital hyperammonemia, type I |
| RS201716492 |
NPAT
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS201716815 |
WDR45
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurodegeneration with brain iron accumulation 5, Neurodegeneration with brain iron accumulation 5 |
| RS201717599 |
TP53
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Li-Fraumeni syndrome 1 |
| RS201717871 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Myopathy, myofibrillar |
| RS201718067 |
DMD
|
Health Risk |
Conflicting classifications of pathogenicity |
Duchenne muscular dystrophy, Cardiovascular phenotype |
| RS201718371 |
MTR
|
Health Risk |
Pathogenic |
Methylcobalamin deficiency type cblG, Methylcobalamin deficiency type cblG |
| RS201718767 |
SCN2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Seizures, benign familial infantile |
| RS201718893 |
TRIO
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS201718910 |
PEX3
|
Health Risk |
Conflicting classifications of pathogenicity |
Peroxisome biogenesis disorder 10A (Zellweger), Peroxisome biogenesis disorder 10A (Zellweger) |
| RS201719002 |
DIAPH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant nonsyndromic hearing loss 1, Progressive microcephaly-seizures-cortical blindness-developmental delay syndrome |
| RS201719096 |
PRSS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary pancreatitis, Hereditary pancreatitis |
| RS201719223 |
COL7A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Epidermolysis bullosa dystrophica, Epidermolysis bullosa dystrophica |
| RS201719374 |
DIS3L2
|
Health Risk |
Conflicting classifications of pathogenicity |
Perlman syndrome, DIS3L2-related disorder |
| RS201719702 |
NEB
|
Health Risk |
Pathogenic/Likely pathogenic |
Nemaline myopathy, Arthrogryposis multiplex congenita 6 |
| RS201719745 |
PEX1
|
Health Risk |
Conflicting classifications of pathogenicity |
Zellweger spectrum disorders, PEX1-related disorder |
| RS201719788 |
COL2A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Stickler syndrome type 1, Type 2 collagenopathy |
| RS201719927 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia syndrome |
| RS201720099 |
MPZ
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease, type I |
| RS201720741 |
ALDH7A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Pyridoxine-dependent epilepsy, Pyridoxine-dependent epilepsy |
| RS201720770 |
NAXD
|
Health Risk |
Pathogenic |
NAD(P)HX dehydratase deficiency, NAD(P)HX dehydratase deficiency |
| RS201720771 |
ALPK1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS201720797 |
CUBN
|
Health Risk |
Conflicting classifications of pathogenicity |
Imerslund-Grasbeck syndrome, Proteinuria |
| RS201721215 |
F8
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary factor VIII deficiency disease, Inborn genetic diseases |
| RS201721269 |
SLC12A3
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial hypokalemia-hypomagnesemia, Familial hypokalemia-hypomagnesemia |
| RS201721391 |
OTX2
|
Health Risk |
Conflicting classifications of pathogenicity |
Anophthalmia-microphthalmia syndrome, Inborn genetic diseases |
| RS201721676 |
TCF4
|
Health Risk |
Conflicting classifications of pathogenicity |
Pitt-Hopkins syndrome, Pitt-Hopkins syndrome |
| RS201721812 |
TUBGCP6
|
Health Risk |
Conflicting classifications of pathogenicity |
Microcephaly and chorioretinopathy 1, Microcephaly and chorioretinopathy 1 |
| RS201721894 |
MCPH1
|
Health Risk |
Likely pathogenic |
Microcephaly 1, primary |
| RS201721923 |
OTOG
|
Health Risk |
Conflicting classifications of pathogenicity |
OTOG-related disorder, OTOG-related disorder |
| RS201722260 |
SLC39A5
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS201722265 |
COL6A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Collagen 6-related myopathy, Bethlem myopathy 1A |
| RS201722303 |
TNNT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Nemaline myopathy 5, Inborn genetic diseases |
| RS201722703 |
MSH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS201722909 |
ERMARD
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS201723337 |
IL12RB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency, IL12RB1-related disorder |
| RS201723380 |
VPS13B
|
Health Risk |
Conflicting classifications of pathogenicity |
Cohen syndrome, Inborn genetic diseases |
| RS201723702 |
SPG7
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia, Hereditary spastic paraplegia 7 |
| RS201724032 |
TRIOBP
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 28, TRIOBP-related disorder |
| RS201724038 |
ABCC8
|
Health Risk |
Conflicting classifications of pathogenicity |
Maturity-onset diabetes of the young, Transitory neonatal diabetes mellitus |
| RS201724183 |
COL4A4
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS201724656 |
SACS
|
Health Risk |
Conflicting classifications of pathogenicity |
Charlevoix-Saguenay spastic ataxia, Spastic paraplegia |
| RS201724962 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS201725344 |
MAPKBP1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS201725369 |
ANO5
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2L, Gnathodiaphyseal dysplasia |
| RS201725483 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Cardiovascular phenotype |
| RS201726041 |
C3
|
Health Risk |
Conflicting classifications of pathogenicity |
Age related macular degeneration 9, Atypical hemolytic-uremic syndrome with C3 anomaly |
| RS201726098 |
PRKDC
|
Health Risk |
Conflicting classifications of pathogenicity |
Severe combined immunodeficiency due to DNA-PKcs deficiency, Severe combined immunodeficiency due to DNA-PKcs deficiency |
| RS201726114 |
KIF22
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS201726150 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS201726258 |
USH2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinal dystrophy, Inborn genetic diseases |
| RS201726457 |
CDH3
|
Health Risk |
Conflicting classifications of pathogenicity |
EEM syndrome, EEM syndrome |
| RS201726554 |
ESRRB
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 35, ESRRB-related disorder |
| RS201726560 |
OTOF
|
Health Risk |
Conflicting classifications of pathogenicity |
— |